After 400% Surge, Should Investors Care About Monte Rosa Insider Sale?
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
This quick comparison explains why price indices and total return indices diverge, focusing on dividends and reinvestment effects.
28,562 articlesA biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Active ETFs are reshaping how people think about investing. This article explains what they are, when they can beat p...
Patience and a long time horizon are the most powerful tools in any investor’s kit. This guide explains why waiting f...
As Warren Buffett steps back, Greg Abel’s potential move to buy a stock Buffett loves has investors buzzing. This art...
A veteran market strategist warns that the next six to twelve months could bring volatility as a flood of tech IPOs t...
As markets shift, investors wonder if the Vanguard Total International Stock ETF is a smarter pick today than a month...
A modest uptick followed an analyst upgrade, but the implications go beyond a single day. This article breaks down wh...
Two powerful forces are tightening the world’s oil supply. This guide explains what that means for investors and poin...
A director sold about $128,000 of Cognex shares, prompting questions about the stock's outlook. This guide breaks dow...
A fresh analysis finds a single 65-year-old must accumulate roughly $898,000 to fund a comfortable retirement, with h...
Gas costs are now a top factor for swing voters as they budget for daily needs and summer travel. This report tracks ...
Starting with almost nothing, one investor grew a portfolio of 11 real estate deals in six years. Learn the step-by-s...